Reuters logo
BRIEF-Recro Pharma completes enrollment in Phase III safety study of IV Meloxicam
February 27, 2017 / 12:27 PM / in 10 months

BRIEF-Recro Pharma completes enrollment in Phase III safety study of IV Meloxicam

Feb 27 (Reuters) - Recro Pharma Inc

* Recro Pharma completes enrollment in Phase III safety study of IV Meloxicam Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below